Meridian Bioscience Stock Price and Value Analysis

Should you buy Meridian Bioscience stock? (NasdaqGS:VIVO). Let's see how it does in our automated value investing analysis system.

  • This company has a high dividend yield.
  • This company is solid.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.

VIVO Free Cash Flow Trend

Based on historical returns, we believe that Meridian Bioscience can grow its free cash at a rate of about 2%. That's positive!

Free Cash Flow trendline for VIVO
Free Cash Flow trendline for Meridian Bioscience

Inside the VIVO Numbers

VIVO Price
(Meridian Bioscience stock price per share)
[?] VIVO Fair Price
(based on intrinsic value)
[?] VIVO Safety Price (based on a variable margin of safety) $6.94
[?] PE Ratio versus Sector 41% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Cash Yield 6.42%
[?] Free Cash Flow Jitter 73%
[?] Dividend Yield 3%

Is Meridian Bioscience Stock on Sale?

We believe that Meridian Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Meridian Bioscience looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy VIVO Stock?

Does Meridian Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.